Healthline Quotes Dr. Ilan Danan: FDA Approves Drug QULIPTA for Chronic Migraine
Dr. Danan weighs on this additional option for those experiencing the debilitating condition. Article Link: FDA Approves Drug QULIPTA for Chronic Migraine (healthline.com) Atogepant works by blocking a chemical called CGRP that plays a role in migraine. “CGRP is short for calcitonin gene-related peptide… CGRP released in the brain can affect a nerve…
Details